Related Experiment Video

Updated: Feb 20, 2026

Preparation of a Non-Cardiomyocyte Cell Suspension for Single-Cell RNA Sequencing from a Post-Myocardial Infarction Adult Mouse Heart
05:54

Preparation of a Non-Cardiomyocyte Cell Suspension for Single-Cell RNA Sequencing from a Post-Myocardial Infarction Adult Mouse Heart

Published on: February 3, 2023

2.7K

When RNAs come full circle: new regulators of healing after myocardial infarction

Carlos Zaragoza1,2

  • 1Unidad Mixta de Investigación Cardiovascular, Universidad Francisco de Vitoria, Hospital Ramon y Cajal (IRYCIS), Madrid, Spain.

European Heart Journal
|February 18, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

7.3K
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

9.1K

Related Experiment Videos

Last Updated: Feb 20, 2026

Preparation of a Non-Cardiomyocyte Cell Suspension for Single-Cell RNA Sequencing from a Post-Myocardial Infarction Adult Mouse Heart
05:54

Preparation of a Non-Cardiomyocyte Cell Suspension for Single-Cell RNA Sequencing from a Post-Myocardial Infarction Adult Mouse Heart

Published on: February 3, 2023

2.7K
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

7.3K
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

9.1K

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

228
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
228

Articles linked to this work by shared authors, journal, and citation graph.

Endothelial Integrin-Linked Kinase (ILK) Deficiency Promotes Endothelial Activation and Cardiovascular Dysfunction via Receptor Interacting Protein Kinase-1 (RIPK1) Enriched-Extracellular Vesicle Signalling.

Journal of extracellular vesicles·2026

A Novel Minimally Invasive Porcine Model of Functional Tricuspid Regurgitation.

Journal of cardiovascular development and disease·2026

ILK-Dependent Modulation of DPP4 Prevents Progression of Calcific Aortic Valve Disease.

Arteriosclerosis, thrombosis, and vascular biology·2026

Dynamic microRNA Signatures as Biomarkers for Cardiac Ischemia and Remodeling.

International journal of molecular sciences·2026

Atherogenic dyslipidaemia and residual cardiovascular risk: Understanding the link to heart disease.

European journal of clinical investigation·2026

Extracellular Vesicles in Calcific Aortic Valve Disease: From Biomarkers to Drug Delivery Applications.

Biomolecules·2025

Exercise stress echocardiography for diagnosis of heart failure with preserved ejection fraction: a multicentre study.

European heart journal·2026

Nighttime light exposure and cardiac structure and function.

European heart journal·2026

Subclinical liver disease and incident cardiovascular events.

European heart journal·2026

Reconciling evidence-based and personalized medicine: perspectives in heart failure and cardiomyopathies.

European heart journal·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us